Esophageal lesions in myeloproliferative neoplasms

Endoscopy. 2012:44 Suppl 2 UCTN:E173-4. doi: 10.1055/s-0031-1291754. Epub 2012 May 23.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Carmustine / administration & dosage
  • Cyclophosphamide / administration & dosage
  • Esophageal Neoplasms / complications
  • Esophageal Neoplasms / drug therapy
  • Esophageal Neoplasms / pathology*
  • Etoposide / administration & dosage
  • Humans
  • Male
  • Myeloproliferative Disorders / complications
  • Myeloproliferative Disorders / drug therapy
  • Myeloproliferative Disorders / pathology*
  • Prednisolone / administration & dosage
  • Ulcer / complications
  • Ulcer / drug therapy
  • Ulcer / pathology*

Substances

  • Etoposide
  • Cyclophosphamide
  • Prednisolone
  • Carmustine

Supplementary concepts

  • CBV protocol